Your browser doesn't support javascript.
COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases.
Ghiasvand, Fereshteh; Ghadimi, Maryam; Sadr, Sara; Jafari, Fatemeh; Manafi, Navid; Ahmadinejad, Zahra; Tirgar, Samaneh; Seyed Alinaghi, Seyed Ahmad.
  • Ghiasvand F; Liver Transplantation Research Center, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran,, Iran.
  • Ghadimi M; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD,, United States.
  • Sadr S; Mazandaran University of Medical Sciences, School of Medicine, Sari,, Iran.
  • Jafari F; Iran University of Medical Sciences, School of Medicine, Tehran,, Iran.
  • Manafi N; Iran University of Medical Sciences, School of Medicine, Tehran,, Iran.
  • Ahmadinejad Z; Liver Transplantation Research Center, Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran,, Iran.
  • Tirgar S; Department of Infectious Diseases, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Tehran,, Iran.
  • Seyed Alinaghi SA; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran,, Iran.
Infect Disord Drug Targets ; 21(6): e170721188439, 2021.
Article in English | MEDLINE | ID: covidwho-948017
ABSTRACT

BACKGROUND:

Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is limited data on its efficacy. CASE PRESENTATION We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome.

CONCLUSION:

We have presented evidence of the potential beneficial effect of the azithromycin in the treatment of patients with COVID-19 in three different clinical settings. More evidence is needed regarding the microbiological data, safety, and efficacy of this medication in the management of COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Azithromycin / COVID-19 Drug Treatment Type of study: Case report / Prognostic study Limits: Humans Language: English Journal: Infect Disord Drug Targets Journal subject: Communicable Diseases / Drug Therapy Year: 2021 Document Type: Article Affiliation country: 1871526520999201126203510

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Azithromycin / COVID-19 Drug Treatment Type of study: Case report / Prognostic study Limits: Humans Language: English Journal: Infect Disord Drug Targets Journal subject: Communicable Diseases / Drug Therapy Year: 2021 Document Type: Article Affiliation country: 1871526520999201126203510